Qingrong Liu, Ju Mei, Hongliang Zhang, Wenbing Zhou, Kejin Qiu, Qing Zhou, Yang Chen, Wei Duan, Changping Zhou, Min Tang, Jianbing Huang, Haixia Liu, Qingqing Liu, Rencao Chang, Guannan Niu, Yuxin Zhang, Tao Wu, Ting Zhang, Weiyi Fang, Yongjian Wu, Runlin Gao
Transcatheter aortic valve implantation (TAVI) has become a therapeutic treatment for severe symptomatic patients with aortic stenosis. This study aimed to test a novel transcatheter aortic self-expandable bioprosthesis-the ScienCrown system (Lepu Medtech Inc., Beijing, China)-and evaluate the safety of the new device during TAVI. ScienCrown aortic valve implantation was performed on 10 patients. Clinical assessment was performed at baseline, post procedure, and after 1 year. Clinical outcomes and adverse events were assessed according to Valvular Academic Research Consortium-3 criteria...
January 15, 2024: American Journal of Cardiology